BioSpace News Archive

Business

Immutep Quarterly Activities Report - October 25, 2022

Immutep Limited, a clinical-stage biotechnology company developing novel immunotherapies for cancer and autoimmune disease, provides an update on the ongoing development of its product candidates, eftilagimod alpha and IMP761 for the quarter ended 30 September 2022.

October 25, 2022
·
8 min read
MedAlliance SELUTION SLR Receives Coronary FDA IDE Approval

SELUTION SLR™, MedAlliance’s novel sirolimus-eluting balloon, has received FDA Investigational Device Exemption (IDE) approval to initiate its coronary pivotal clinical trial.

October 25, 2022
·
3 min read
Drug Development

Quadriga BioSciences Announces Completion of Enrollment in Phase 1 Study of QBS72S for Solid Tumors

Quadriga BioSciences, a clinical-stage oncology company developing QBS10072S (QBS72S) for the targeted treatment of cancer, today announced the completion of enrollment for a Phase 1 dose escalation study investigating QBS72S in patients with advanced or metastatic solid cancers.

October 25, 2022
·
2 min read
Biotech Bay

Tenon Medical’s Catamaran(TM) SI Joint Fusion System Receives Institutional Review Board Approval for Two Strategic Post Market Studies

Tenon Medical, Inc. today announced Institutional Review Board (“IRB”) approval from WCG IRB for two separate Tenon-sponsored post market clinical studies of the Company’s Catamaran SI Joint Fusion System (the “Catamaran”).

October 25, 2022
·
4 min read
Business

Triumvira Immunologics Appoints Life Sciences Industry Leader Robert Williamson as President and Chief Business Officer

Triumvira Immunologics today announced the appointment of Robert Williamson as President and Chief Business Officer.

October 25, 2022
·
3 min read